Upsher-Smith
Upsher-Smith expands portfolio with launch of Glatiramer Acetate Injection
Latest Addition Advances Upsher-Smith's Strategy to Expand Its Portfolio of Complex Generic Medicines and Broaden Patient Access.
Upsher-Smith Labs intros KYMBEE (deflazacort) Oral Suspension
Liquid formulation enhances treatment flexibility.
Upsher-Smith launches cyclosporine ophthalmic emulsion
“The launch of cyclosporine ophthalmic emulsion reflects Upsher-Smith’s continued momentum in expanding and diversifying its U.S. portfolio.”
Upsher-Smith launches Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, USP
First prescription ear drop suspension advances portfolio diversification strategy.
Upsher-Smith launches KYMBEE (deflazacort) Tablets
Company reinforces commitment to rare disease community through its Promise of Support Program.